Trump's Regeneron Treatment Is a Tangled Ethical Mess

Barron's - 08 Oct 2020
The president's use of an experimental drug, outside of clinical trials, raises questions about preferential treatment and imperils evidence-based ...

Regeneron inks big new coronavirus antibody supply deal worth up to $2.6B

FiercePharma - 14 Jan 2021
Regeneron inks big new coronavirus antibody supply deal worth up to $2.6B ...

Answer Man: Regeneron treatment available at local hospitals?

Citizen Times - 15 Jan 2021
Answer Man: Regeneron treatment available at local hospitals? ...

JPM: Regeneron execs say 'it's a problem' how few COVID-19 patients are getting antibody treatments

FiercePharma - 12 Jan 2021
JPM: Regeneron execs say 'it's a problem' how few COVID-19 patients are getting antibody treatments ...

JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon

FierceBiotech - 11 Jan 2021
JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon ...

Regeneron's CEO and CSO could nab a whopping $1.4B in bonuses—if the pipeline pumps up investors

FiercePharma - 06 Jan 2021
Regeneron's CEO and CSO could nab a whopping $1.4B in bonuses—if the pipeline pumps up investors ...

Is Regeneron Stock Heading to $590?

Motley Fool - 13 Jan 2021
Is Regeneron Stock Heading to $590? ...

Regeneron says it will continue trial of COVID antibody cocktail as latest data show positive results

MarketWatch - 30 Dec 2020
Regeneron says it will continue trial of COVID antibody cocktail as latest data show positive results ...

Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?

The Motley Fool - 14 Jan 2021
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock? ...

Regeneron (REGN) Upgrade Lifts Range-Bound Biotech Stocks

Investopedia - 11 Jan 2021
Regeneron (REGN) Upgrade Lifts Range-Bound Biotech Stocks ...

Regeneron says COVID-19 antibody therapy will likely help against variants

Yahoo Finance - 11 Jan 2021
Regeneron says COVID-19 antibody therapy will likely help against variants ...

JPM, Day 1: Sanofi grabs a British biotech, Regeneron hopes for FDA hold lift and more

FierceBiotech - 11 Jan 2021
JPM, Day 1: Sanofi grabs a British biotech, Regeneron hopes for FDA hold lift and more ...

Regeneron Upgraded to Buy at Citi on Eczema Drug Potential

TheStreet - 08 Jan 2021
Regeneron Upgraded to Buy at Citi on Eczema Drug Potential ...

East Greenbush police, FBI respond to bomb threat at Regeneron

Times Union - 13 Jan 2021
East Greenbush police, FBI respond to bomb threat at Regeneron ...

US Government to Purchase Additional Doses of Regeneron's COVID-19 Antibody Cocktail

BioPharm International - 15 Jan 2021
US Government to Purchase Additional Doses of Regeneron's COVID-19 Antibody Cocktail ...

Regeneron Stock Has Fallen. Why It Could Be Time to Buy.

Barron's - 08 Jan 2021
Regeneron Stock Has Fallen. Why It Could Be Time to Buy. ...

Regeneron And Lilly Antibody Drugs Against COVID-19 Underused : Shots - Health News

NPR - 22 Dec 2020
Regeneron And Lilly Antibody Drugs Against COVID-19 Underused : Shots - Health News ...

Regeneron's quest for a COVID-19 antibody drug

The Japan Times - 22 Dec 2020
Regeneron's quest for a COVID-19 antibody drug ...

Regeneron Winner from TC!

The Zebra - 13 Jan 2021
Regeneron Winner from TC! ...

Schools: Dinosaurs, One-Word Challenge and Regeneron Scholar

http://www.huntingtonNow.com - 15 Jan 2021
Schools: Dinosaurs, One-Word Challenge and Regeneron Scholar ...

Regeneron